Table 2 Baseline characteristics of the study group at t=0

From: Is there an effect of intranasal insulin on development and behaviour in Phelan-McDermid syndrome? A randomized, double-blind, placebo-controlled trial

n=25

Mean (SD)

Median

Range

Age (months)

82.5 (47.8)

75.0

13–189

Deletion size (Mb)

3.9 (2.5)

3.4

0.18–7.8

Cognitive DAE at start (months)

18.0 (11.1)

14.0

5.1–53

Mean weight at start (kg)

25.3 (13.8)

24.0

8–60

Head circumference at start (cm)

50.8 (3.2)

50.5

44.7–56